Weekly Update: New diabetes clinical trial (13 items)

New diabetes clinical trial: Breaking up Sedentary Time to Improve Glucose Control in a Population at Risk for Developing Type 2 Diabetes Published on: September 13, 2021 at 07:00PM Conditions:   Pre-diabetes;   Overweight and Obesity Interventions:   Behavioral: BREAK;   Behavioral: ONE Sponsor:   University of Colorado, Denver Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05041491?term=diabetes&sfpd_d=14 September 13, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation Published on: September 13, 2021 at 07:00PM Conditions:   Diabetes Mellitus;   Liver Transplant; Complications Interventions:   Drug: Dapagliflozin 10Mg Tab;   Drug: Sitagliptin 100mg Sponsor:   Medanta, The Medicity, India Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05042505?term=diabetes&sfpd_d=14 September 13, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: A Learning Algorithm for MDI Individuals With Type 1 Diabetes to Adjust Recommendations for High Fat Meals and Exercise Management Published on: September 13, 2021 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Device: Sensor augmented MDI therapy plus mobile application Sponsor:   McGill University Recruiting https://clinicaltrials.gov/ct2/show/NCT05041621?term=diabetes&sfpd_d=14 September 13, 2021 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: HIT on Hypoglycaemic Risk in T1D Published on: September 14, 2021 at 07:00PM Condition:   Type1diabetes Interventions:   Behavioral: moderate intensity continous training;   Behavioral: high intensity interval training Sponsors:   Liverpool John Moores University;   Society for Endocrinology;   Royal Liverpool University Hospital;   University of Birmingham;   University of Exeter Completed https://clinicaltrials.gov/ct2/show/NCT05044442?term=diabetes&sfpd_d=14 September 14, 2021 at 07:22PM via ClinicalTrials.gov New diabetes clinical trial: Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus Published on: September 14, 2021 at 07:00PM Condition:   Type2 Diabetes Intervention:   Drug: Duvie(Lobeglitazone) tab 0.5mg Sponsor:   Chong Kun Dang Pharmaceutical Completed https://clinicaltrials.gov/ct2/show/NCT05043467?term=diabetes&sfpd_d=14 September 14, 2021 at 07:22PM via ClinicalTrials.gov New diabetes clinical trial: Postprandial VLDL-triglycerid Metabolism in Type 2 Diabetes Patients With and Without NAFLD Published on: September 14, 2021 at 07:00PM Conditions:   NAFLD;   Type 2 Diabetes Intervention:   Dietary Supplement: High-fat mixed-meal tolerance test (HF-MMT) Sponsors:   University of Aarhus;   Danish Diabetes Academy Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05044130?term=diabetes&sfpd_d=14 September 14, 2021 at 07:22PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Published on: September 16, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Co-formulation NNC0480 0389+Semaglutide A 10/1 mg/mL;   Drug: semaglutide 1.34 mg/mL (placebo);   Drug: Semaglutide 1.34 mg/mL;   Drug: NNC0480-0389 A 10 mg/mL Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05046873?term=diabetes&sfpd_d=14 September 16, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: Personalized Dietary Management in Type 2 Diabetes Published on: September 16, 2021 at 07:00PM Condition:   T2D Interventions:   Behavioral: Social Cognitive Theory (SCT)-Based Behavioral Counseling;   Behavioral: Isocaloric Mediterranean Diet Advice;   Behavioral: Personalized Guidance to Minimize Postprandial Glycemic Response (PPGR) Sponsors:   NYU Langone Health;   National Institute of Nursing Research (NINR) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05046886?term=diabetes&sfpd_d=14 September 16, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium Published on: September 15, 2021 at 07:00PM Condition:   Bipolar Disorder Interventions:   Drug: Anhydrous Amiloride Hydrochloride;   Drug: Placebo Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05044611?term=diabetes&sfpd_d=14 September 16, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI Published on: September 16, 2021 at 07:00PM Conditions:   ST Elevation Myocardial Infarction;   Diabetes Mellitus Intervention:   Sponsor:   German Diabetes Center Recruiting https://clinicaltrials.gov/ct2/show/NCT05046483?term=diabetes&sfpd_d=14 September 16, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic Nephropathy Published on: September 17, 2021 at 07:00PM Condition:   Diabetic Kidney Disease Intervention:   Sponsor:   Yiming Mu Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05047471?term=diabetes&sfpd_d=14 September 17, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus Published on: September 17, 2021 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Drug: LY3502970;   Drug: Dulaglutide;   Drug: Placebo Sponsor:   Eli Lilly and Company Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05048719?term=diabetes&sfpd_d=14 September 17, 2021 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: Electronic Frailty Index (eFI)Cacious-Diabetes Care Published on: September 17, 2021 at 07:00PM Conditions:   Diabetes;   Type2 Diabetes Intervention:   Behavioral: Pharmacist-Led Optimization Intervention Sponsor:   Wake Forest University Health Sciences Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05047237?term=diabetes&sfpd_d=14 September 17, 2021 at 06:22PM via ClinicalTrials.gov